(NewsDirect)
Avricore Health CEO Hector Bremner tellsProactive's Stephen Gunnion that HealthTab has been selected for aUK-based feasibility study, marking an important internationalexpansion.
Avricore Health hasachieved success in Canada with HealthTab, the company's leadingpharmacy-based platform for testing and health data management. Now,in partnership with Barts Hart Centre and HEART UK, the platform willbe used to support NHS England's efforts to enhance communitypharmacy-driven care for cardiovascular disease.
The success of the NHS's Health Checkprogram, which conducted over a million opportunistic blood pressurechecks, revealed the need for advanced screening methods.
Bremner emphasized the increasing role ofcommunity pharmacies in global healthcare systems, offering on-demandcare beyond emergency rooms. The feasibility study will initiallyfocus on five locations in London, with plans to rapidly scale up to50 and beyond.
Avricore Healthenvisions HealthTab as a global solution, with consistent demandacross markets, and the UK's supportive pharmacy infrastructureand population size make it an ideal starting point.
Bremnerexpressed optimism about HealthTab's potential to revolutionizehealthcare delivery internationally.
ContactDetails
Proactive Studio
+1 347-449-0879
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.